West Pharmaceutical Services Inc at KeyBanc Healthcare Forum Transcript
This is Paul Knight, the analyst covering life science at KeyBanc Capital Markets. With me today is Anne Snopkowski, who's on my team as well. We'll be running some Q&A. And then we have, of course, Bob McMahon, the Chief Financial Officer of West Pharma; John Sweeney, Head of Investor Relations.
Questions & Answers
But that kind of pops into my first question, Bob. Agilent, of course, very, very well-known firm, I followed it since the 99 spin, I believe, from HP. What do you like about the West business now that you've been here a little bit?
Yes. Yes, Paul, Great. Thanks to you and Anna for having us. We really appreciate it. And what I'd say is the thing that's really super exciting about West is I think it's a business model that's fairly rarely matched in the industry.
And when I think
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
